High-density miniaturized thermal shift assays as a general strategy for drug discovery MW Pantoliano, EC Petrella, JD Kwasnoski, VS Lobanov, J Myslik, E Graf, ... Journal of biomolecular screening 6 (6), 429-440, 2001 | 1136 | 2001 |
Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells BL Grasberger, T Lu, C Schubert, DJ Parks, TE Carver, HK Koblish, ... Journal of medicinal chemistry 48 (4), 909-912, 2005 | 593 | 2005 |
Phospholipid/alkanethiol bilayers for cell-surface receptor studies by surface plasmon resonance AL Plant, M Brighamburke, EC Petrella, DJ Oshannessy Analytical Biochemistry 226 (2), 342-348, 1995 | 273 | 1995 |
1, 4-Benzodiazepine-2, 5-diones as small molecule antagonists of the HDM2–p53 interaction: discovery and SAR DJ Parks, LV LaFrance, RR Calvo, KL Milkiewicz, V Gupta, J Lattanze, ... Bioorganic & medicinal chemistry letters 15 (3), 765-770, 2005 | 271 | 2005 |
Natural products reveal cancer cell dependence on oxysterol-binding proteins AWG Burgett, TB Poulsen, K Wangkanont, DR Anderson, C Kikuchi, ... Nature chemical biology 7 (9), 639-647, 2011 | 254 | 2011 |
Structural requirements and thermodynamics of the interaction of proline peptides with profilin EC Petrella, LM Machesky, DA Kaiser, TD Pollard Biochemistry 35 (51), 16535-16543, 1996 | 134 | 1996 |
Crystal structure of the actin-binding protein actophorin from Acanthamoeba SA Leonard, AG Gittis, EC Petrella, TD Pollard, EE Lattman Nature Structural Biology 4 (5), 369-373, 1997 | 89 | 1997 |
Primary structure of cobra complement component C3. DC Fritzinger, EC Petrella, MB Connelly, R Bredehorst, CW Vogel Journal of immunology (Baltimore, Md.: 1950) 149 (11), 3554-3562, 1992 | 75 | 1992 |
Decrypting the biochemical function of an essential gene from Streptococcus pneumoniae using ThermoFluor® technology TE Carver, B Bordeau, MD Cummings, EC Petrella, MJ Pucci, ... Journal of Biological Chemistry 280 (12), 11704-11712, 2005 | 72 | 2005 |
Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps. MW Ollert, JV Kadlec, K David, EC Petrella, R Bredehorst, CW Vogel Journal of immunology (Baltimore, Md.: 1950) 153 (5), 2213-2221, 1994 | 71 | 1994 |
The three-dimensional structure of the ZAP-70 kinase domain in complex with staurosporine: implications for the design of selective inhibitors L Jin, S Pluskey, EC Petrella, SM Cantin, JC Gorga, MJ Rynkiewicz, ... Journal of Biological Chemistry 279 (41), 42818-42825, 2004 | 67 | 2004 |
Immunoreactivity and function of oligosaccharides in cobra venom factor. DC Gowda, EC Petrella, TT Raj, R Bredehorst, CW Vogel Journal of immunology (Baltimore, Md.: 1950) 152 (6), 2977-2986, 1994 | 64 | 1994 |
C3-cleaving membrane proteinase. A new complement regulatory protein of human melanoma cells. MW Ollert, R Frade, A Fiandino, M Panneerselvam, EC Petrella, M Barel, ... Journal of immunology (Baltimore, Md.: 1950) 144 (10), 3862-3867, 1990 | 47 | 1990 |
Complement killing of human neuroblastoma cells: A cytotoxic monoclonal antibody and its F (ab)'2-cobra venom factor conjugate are equally cytotoxic H Juhl, EC Petrella, NKV Cheung, R Bredehorst Molecular Immunology 27 (10), 957-964, 1990 | 46 | 1990 |
Antibody conjugates with cobra venom factor: synthesis and biochemical characterization EC Petrella, SD Wilkie, CA Smith, AC Morgan Jr, CW Vogel Journal of immunological methods 104 (1-2), 159-172, 1987 | 41 | 1987 |
> Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells H Juhl, EC Petrella, NKV Cheung, R Bredehorst, CW Vogel Immunobiology 197 (5), 444-459, 1997 | 40 | 1997 |
Kinase inhibitor profiling using chemoproteomics M Schirle, EC Petrella, SM Brittain, D Schwalb, E Harrington, ... Kinase Inhibitors: Methods and Protocols, 161-177, 2012 | 17 | 2012 |
Molecular cloning of cobra venom factor and cobra C3: Structural homology with human C3 DC Fritzinger, MB Connelly, EC Petrella, R Bredehorst, CW Vogel FASEB J 4, A1903, 1990 | 12 | 1990 |
Molecular Basis of Complement Resistance of Human Melanoma Cells Expressing the C3-cleaving Membrane Protease p65 MW Ollert, JV Kadlec, EC Petrella, R Bredehorst, CW Vogel Cancer research 53 (3), 592-599, 1993 | 9 | 1993 |
V., Bredehorst, R., and Vogel, CW. Complement killing of human neuroblastoma cells: a cytotoxic monoclonal antibody and its F (ab) 2-CVF conjugate are equally cytotoxic H Juhl, EC Petrella, NK Cheung Mol. Immunol 27, 957-964, 1990 | 6 | 1990 |